The recent SARAH and SIRveNIB trials looked to clarify the impact of SIRT versus sorafenib in patients with locally advanced HCC. What did they show? What are the implications for practice? And what other recent publications can help to shed light on this treatment question? The proceeding e-learning course will take you through our experts’ views on the results from these important studies.

EACCME Accreditation

COR2ED Checkpoint, made available on and organized by COR2ED, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

Information on the process to convert EACCME credit to AMA credit can be found at